Johnson & Johnson has offered to pony up $8.9 billion over 25 years to settle all current and future claims that its talc baby powder contained asbestos and caused cancer to some consumers. It is one of the largest consumer liability settlements in history.

The company emphasized that the issues are quite rare. No devices are being recalled, and it is not recommended that customers stop using them. 

Others such as the AMA and the American Lung Association similarly blasted the decision, which could jeopardize coverage for preventative care.

Such behaviors may lead to delays in cancer diagnosis and treatment and adverse outcomes, experts wrote Tuesday in Radiology. 

Healthcare is one of the biggest areas of opportunity for AI, with more than 500 health AI algorithms cleared by the FDA over the last several years.

A popular marketer of handheld ultrasound devices has won FDA approval for an AI-enabled B-line quantification tool for use with patients suspected of having compromised lung function.

The agency, which is charged with preventing fraud, deception and unfair business practices, said Illumina’s acquisition of Grail would stifle competition and innovation in the U.S. market for life-saving cancer tests.

According to CMS, MA plans will see an average payment increase of 3.32% from 2023 to 2024, worth approximately $13.8 billion in increases for next year.